Navigation Links
Amylin Pharmaceuticals and Biocon Limited Enter a Global Development and Commercialization Agreement for a Novel Peptide Hybrid
Date:9/10/2009

SAN DIEGO and BANGALORE, India, Sept. 10 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Biocon, Limited (NSE: BIOCON) announced today that they have entered into an exclusive agreement to jointly develop, commercialize and manufacture a novel peptide therapeutic for the potential treatment of diabetes. Amylin and Biocon will collaborate to develop the therapeutic potential of the compound and share development costs. Research will center on Amylin's "phybrid" technology. A phybrid is a peptide hybrid molecule that combines the pharmacological effects of two peptide hormones into a single molecular entity.

Under the terms of the Development and Commercialization Agreement, Amylin will provide expertise in peptide hormone development, particularly in the area of phybrid technology, as well as metabolic disease therapeutics. Biocon will utilize its expertise in recombinant microbial expression to manufacture the compound and also leverage its experience in preclinical and clinical development of diabetes products.

"This agreement fully leverages the synergistic capabilities of the two companies," said Kiran Mazumdar-Shaw, Chairman and Managing Director, Biocon, Ltd. "Amylin's knowledge of peptide therapeutics and their leadership in the diabetes market, paired with Biocon's capabilities in process development, manufacturing and clinical development, provides this global program with the potential to effectively bring a novel therapy to patients living with diabetes."

"This program could unleash the potential of cutting-edge peptide science to transform the lives of patients with diabetes," said Daniel M. Bradbury, President and Chief Executive Officer, Amylin Pharmaceuticals. "We are pleased to work with Biocon, a biologics
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Amylin Pharmaceuticals Reports Second Quarter Financial Results
2. Amylin Pharmaceuticals to Present Compelling Efficacy and Safety Data From Diabetes Programs at ADA 2009
3. Amylin Announces Preliminary Results of Annual Meeting of Stockholders
4. Amylin Advises All Shareholders to Vote Their Blue Proxy Card Today
5. Three Independent Proxy Advisory Firms Support Stockholder Nominees in Amylin Proxy Fight
6. Amylin Issues Statement Regarding Open Letter From Icahn
7. Icahn Issues Open Letter to Amylin Shareholders
8. Amylin Sends Letter to Shareholders
9. Amylin Pharmaceuticals Reports First Quarter Financial Results
10. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
11. Amylin Pharmaceuticals to Webcast First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... 07, 2015 , ... Leading healthcare consulting firm Hammes Company ... Vice President, heading the firm’s Healthcare Advisory Services division. , Mr. Warden will ... providers’ needs in ways that strengthen their position in the marketplace. The Healthcare ...
(Date:7/7/2015)... ... ... a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group A matches ... Stadium. , The 2015 CONCACAF Gold Cup is now upon us as Group A ... soil, will kick off in Frisco, CA from the Toyota Stadium and will feature two ...
(Date:7/7/2015)... ... July 07, 2015 , ... Greatist today announced the ... helps active people find the most fun activities to do with friends. , The ... It also increases Greatist’s opportunity for events, e-commerce, and brand partnerships. , “I’ve been ...
(Date:7/7/2015)... N.J. (PRWEB) , ... July ... ... CTLT), the leading global provider of advanced delivery technologies and development solutions ... signed an exclusive licensing agreement with Excelimmune, Inc. to access its antibody ...
(Date:7/7/2015)... ... July 07, 2015 , ... Healthpointe is ... team. Dr. Alupay, an anesthesiologist and pain management specialist, will be evaluating and treating ... as neurological conditions. , After receiving his Bachelor of Science in Biology from the ...
Breaking Medicine News(10 mins):Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 2Health News:Hammes Company Hires Jay Warden to Lead Healthcare Advisory Services 3Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:Greatist Acquires Active Lifestyle Brand Blood, Sweat & Cheers 2Health News:Catalent Biologics Adds New Technology Platform to Enable Antibody Combination Therapies 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 2Health News:Dr. Pedro S. Alupay, M.D., Now Providing Pain Management Services at Healthpointe in Irwindale 3
... CHICAGO, Sept. 18 As economic, social and political ... state,s leading provider of addiction treatment services is expanding its ... afford expensive clinics but also fail to qualify for government-funded ... a 41-year-old non-profit organization, serves more than 29,000 patients in ...
... feelings of isolation remains unclear , FRIDAY, Sept. 18 (HealthDay ... suicide and rural communities that have higher numbers of bars. ... mean more suicides because it does not show cause and ... percent are alcoholics, according to background information in a news ...
... , SAN FRANCISCO, Sept. 18 VIA ... focused on the development of compounds for the treatment of ... 2009, it received a deficiency letter from the NASDAQ Stock ... the minimum $1.00 per share bid price requirement for continued ...
... , BROOMFIELD, Colo., Sept. 18 Accera, Inc., ... today announced today that it will present at the UBS Global ... , Steve Orndorff, Ph.D., founder, president and CEO, ... Axona (TM) on Monday, September 21 at 11:30 a.m. EDT. ...
... , , WASHINGTON, Sept. 18 ... plan by Senate Finance Chairman Max Baucus, DMLR Chairman Stuart L. ... "The plan released by Senator Baucus is inadequate in addressing the ... and Democrats in the Congress, health care policy experts, opinion leaders, ...
... , BELLEVUE, Wash., Sept. 18 ... today extended its Edifecs5010(TM) Compliance S ... Comparison Manual , a comprehensive version analysis resource that ... changes and includes valuable insights from Subject Matter Experts illuminating ...
Cached Medicine News:Health News:Gateway Responding To Increased Need for Treatment Among Middle-Income Substance Abusers 2Health News:Suicides Higher in Rural Areas With Bars 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 2Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 3Health News:VIA Pharmaceuticals Receives Anticipated Deficiency Notice From NASDAQ 4Health News:Accera, Inc. to Present at UBS Global Life Sciences Conference 2Health News:Statement From Stuart L. Weinstein, MD, Chairman, Doctors for Medical Liability Reform on Senator Baucus' Health Care Reform Proposal 2Health News:Edifecs Extends Its Edifecs5010(TM) Compliance Suite with the Launch of the Edifecs5010(TM) Comparison Manual, a Comprehensive Version Analysis Resource for HIPAA 5010 Migration. 2
(Date:7/7/2015)... The Global Breast Pumps Market is ... an estimated CAGR of 7.6% from 2014 to 2020, according ... of innovative technologies including hand free breast pumps, growing women ... advantages of breast milk are expected to drive breast pump ... untapped growth opportunities in emerging markets such as ...
(Date:7/7/2015)... China , July 7, 2015 /PRNewswire/ -- Mindray ... a leading developer, manufacturer and marketer of medical ... acquire the remaining stake in Wuhan Dragonbio Surgical ... Dragonbio is a domestic medical ... and other surgical products. Prior to today,s announcement, ...
(Date:7/7/2015)... July 7, 2015 EnteroMedics Inc. (NASDAQ: ... use neuroblocking technology to treat obesity, metabolic diseases, and ... announced public offering of 32,000,000 units. Each unit consists of ... warrant to purchase one share of common stock at ... purchase of units in the offering would result in ...
Breaking Medicine Technology:Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 2Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 3Breast Pumps Market To Reach $1,197.7 Million By 2020: Grand View Research, Inc. 4Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $16.0 Million Public Offering of Common Stock and Warrants 3
... Cross-match tubes are available in ... tube contains a clotting activator ... tests where serum is required ... cross-match tube is suitable where ...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
... K2 / gel tubes are for ... molecular diagnostics and for viral load ... blood remain stable at room temperature ... optimal results, it is recommended to ...
... Are offered as either EDTA ... binds the calcium ions and therefore ... and thrombocytes in an EDTA anticoagulated ... to 24 hours. EDTA tubes are ...
Medicine Products: